Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers
Abstract
:1. Introduction
2. Materials and Methods
2.1. Animals and Diets
2.2. Experimental Design
2.3. Induction of Colitis
2.4. Quantitative Real-Time PCR Assay
2.5. Luminex Microbeads Fluorescent Assays
2.6. Statistical Analysis
3. Results
3.1. Effects of High-Fat Diet on Energy Intake, Running Distance, Body Weight and Visceral Adiposity in Sedentary Mice and Those Subjected to Voluntary Exercise
3.2. The Effect of Voluntary Exercise on the Macroscopic and Microscopic Appearance of TNBS-Induced Colitis in Mice Fed a SD or HFD
3.3. The Effects of SD and HFD on the Plasma Concentration of Cytokines, Myokine Irisin, Leptin and Adiponectin in TNBS Colitis Mice with or without Voluntary Exercise
3.4. The Effects of Standard Diet and HFD on the Expression of Proinflammatory Biomarkers in White Adipose Tissue of Mice with TNBS Colitis
4. Discussion
5. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Abraham, C.; Cho, J.H. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361, 2066–2078. [Google Scholar] [CrossRef] [PubMed]
- Desreumaux, P.; Ernst, O.; Geboes, K.; Gambiez, L.; Berrebi, D.; Muller-Alouf, H.; Hafraoui, S.; Emilie, D.; Ectors, N.; Peuchmaur, M.; et al. Inflammatory alterations in mesenteric adipose tissue in Crohn’s disease. Gastroenterology 1999, 117, 73–81. [Google Scholar] [CrossRef]
- Drouet, M.; Dubuquoy, L.; Desreumaux, P.; Bertin, B. Visceral fat and gut inflammation. Nutrition 2012, 28, 113–117. [Google Scholar] [CrossRef] [PubMed]
- Fink, C.; Karagiannides, I.; Bakirtzi, K.; Pothoulakis, C. Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm. Bowel Dis. 2012, 18, 1550–1557. [Google Scholar] [CrossRef] [PubMed]
- Bilski, J.; Mazur-Bialy, A.I.; Wierdak, M.; Brzozowski, T. The impact of physical activity and nutrition on inflammatory bowel disease: The potential role of cross talk between adipose tissue and skeletal muscle. J. Physiol. Pharmacol. 2013, 64, 143–155. [Google Scholar] [PubMed]
- Bilski, J.; Mazur-Bialy, A.I.; Brzozowski, B.; Magierowski, M.; Jasnos, K.; Krzysiek-Maczka, G.; Urbanczyk, K.; Ptak-Belowska, A.; Zwolinska-Wcislo, M.; Mach, T.; et al. Moderate Exercise Training Attenuates the Severity of Experimental Rodent Colitis: The Importance of Crosstalk between Adipose Tissue and Skeletal Muscles. Mediat. Inflamm 2015, 2015, 605071. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.X.; Wang, T.; Zhou, F.; Wang, Y.; Xing, J.W.; Zhang, S.; Gu, S.Z.; Sang, L.X.; Dai, C.; Wang, H.L. Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-gamma activity. Biochem. Biophys. Res. Commun. 2015, 459, 475–480. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.Y.; Liao, J.K. A mouse model of diet-induced obesity and insulin resistance. Methods Mol. Biol. 2012, 821, 421–433. [Google Scholar] [PubMed]
- De La Serre, C.B.; Ellis, C.L.; Lee, J.; Hartman, A.L.; Rutledge, J.C.; Raybould, H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299, G440–G448. [Google Scholar] [CrossRef] [PubMed]
- Bilski, J.; Brzozowski, B.; Mazur-Bialy, A.; Sliwowski, Z.; Brzozowski, T. The role of physical exercise in inflammatory bowel disease. Biomed. Res. Int. 2014, 2014, 429031. [Google Scholar] [CrossRef] [PubMed]
- Bilski, J.; Mazur-Bialy, A.; Brzozowski, B.; Magierowski, M.; Zahradnik-Bilska, J.; Wojcik, D.; Magierowska, K.; Kwiecien, S.; Mach, T.; Brzozowski, T. Can exercise affect the course of inflammatory bowel disease? Experimental and clinical evidence. Pharmacol. Rep. 2016, 68, 827–836. [Google Scholar] [CrossRef] [PubMed]
- Schnyder, S.; Handschin, C. Skeletal muscle as an endocrine organ: PGC-1alpha, myokines and exercise. Bone 2015, 80, 115–125. [Google Scholar] [CrossRef] [PubMed]
- De Bono, J.P.; Adlam, D.; Paterson, D.J.; Channon, K.M. Novel quantitative phenotypes of exercise training in mouse models. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006, 290, R926–R934. [Google Scholar] [CrossRef] [PubMed]
- Bernstein, D. Exercise assessment of transgenic models of human cardiovascular disease. Physiol. Genom. 2003, 13, 217–226. [Google Scholar] [CrossRef] [PubMed]
- Cook, M.D.; Martin, S.A.; Williams, C.; Whitlock, K.; Wallig, M.A.; Pence, B.D.; Woods, J.A. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav. Immun. 2013, 33, 46–56. [Google Scholar] [CrossRef] [PubMed]
- Ho, G.W. Lower gastrointestinal distress in endurance athletes. Curr. Sports Med. Rep. 2009, 8, 85–91. [Google Scholar] [CrossRef] [PubMed]
- Zwolinska-Wcislo, M.; Brzozowski, T.; Ptak-Belowska, A.; Targosz, A.; Urbanczyk, K.; Kwiecien, S.; Sliwowski, Z. Nitric oxide-releasing aspirin but not conventional aspirin improves healing of experimental colitis. World J. Gastroenterol. 2011, 17, 4076–4089. [Google Scholar] [CrossRef] [PubMed]
- Zwolinska-Wcislo, M.; Krzysiek-Maczka, G.; Ptak-Belowska, A.; Karczewska, E.; Pajdo, R.; Sliwowski, Z.; Urbanczyk, K.; Drozdowicz, D.; Konturek, S.J.; Pawlik, W.W.; et al. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines. J. Physiol. Pharmacol. 2011, 62, 357–368. [Google Scholar] [PubMed]
- Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt method. Methods 2001, 25, 402–408. [Google Scholar] [CrossRef] [PubMed]
- Handschin, C.; Spiegelman, B.M. The role of exercise and PGC1α in inflammation and chronic disease. Nature 2008, 454, 463–469. [Google Scholar] [CrossRef] [PubMed]
- Versini, M.; Jeandel, P.Y.; Rosenthal, E.; Shoenfeld, Y. Obesity in autoimmune diseases: Not a passive bystander. Autoimmun. Rev. 2014, 13, 981–1000. [Google Scholar] [CrossRef] [PubMed]
- Richards, J.L.; Yap, Y.A.; McLeod, K.H.; Mackay, C.R.; Marino, E. Dietary metabolites and the gut microbiota: An alternative approach to control inflammatory and autoimmune diseases. Clin. Transl. Immunol. 2016, 5, e82. [Google Scholar] [CrossRef] [PubMed]
- Blain, A.; Cattan, S.; Beaugerie, L.; Carbonnel, F.; Gendre, J.P.; Cosnes, J. Crohn’s disease clinical course and severity in obese patients. Clin. Nutr. 2002, 21, 51–57. [Google Scholar] [CrossRef] [PubMed]
- Steed, H.; Walsh, S.; Reynolds, N. A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland. Obes. Facts 2009, 2, 370–372. [Google Scholar] [CrossRef] [PubMed]
- Seminerio, J.L.; Koutroubakis, I.E.; Ramos-Rivers, C.; Hashash, J.G.; Dudekula, A.; Regueiro, M.; Baidoo, L.; Barrie, A.; Swoger, J.; Schwartz, M.; et al. Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease. Inflamm. Bowel Dis. 2015, 21, 2857–2863. [Google Scholar] [CrossRef] [PubMed]
- Mendall, M.A.; Gunasekera, A.V.; John, B.J.; Kumar, D. Is obesity a risk factor for Crohn’s disease? Dig. Dis. Sci. 2011, 56, 837–844. [Google Scholar] [CrossRef] [PubMed]
- Sheehan, A.L.; Warren, B.F.; Gear, M.W.; Shepherd, N.A. Fat-wrapping in Crohn’s disease: Pathological basis and relevance to surgical practice. Br. J. Surg. 1992, 79, 955–958. [Google Scholar] [CrossRef] [PubMed]
- Alexopoulos, N.; Katritsis, D.; Raggi, P. Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. Atherosclerosis 2014, 233, 104–112. [Google Scholar] [CrossRef] [PubMed]
- Vendrell, J.; Chacon, M.R. TWEAK: A new player in obesity and diabetes. Front Immunol. 2013, 4, 488. [Google Scholar] [CrossRef] [PubMed]
- Paul, G.; Schaffler, A.; Neumeier, M.; Furst, A.; Bataillle, F.; Buechler, C.; Muller-Ladner, U.; Scholmerich, J.; Rogler, G.; Herfarth, H. Profiling adipocytokine secretion from creeping fat in Crohn’s disease. Inflamm. Bowel Dis. 2006, 12, 471–477. [Google Scholar] [CrossRef] [PubMed]
- Batra, A.; Zeitz, M.; Siegmund, B. Adipokine signaling in inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15, 1897–1905. [Google Scholar] [CrossRef] [PubMed]
- Sideri, A.; Stavrakis, D.; Bowe, C.; Shih, D.Q.; Fleshner, P.; Arsenescu, V.; Arsenescu, R.; Turner, J.R.; Pothoulakis, C.; Karagiannides, I. Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1. Am. J. Physiol.-Gastrointest. Liver Physiol. 2015, 308, G591–G604. [Google Scholar] [CrossRef] [PubMed]
- Strober, W.; Fuss, I.J. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011, 140, 1756–1767. [Google Scholar] [CrossRef] [PubMed]
- Bouma, G.; Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003, 3, 521–533. [Google Scholar] [CrossRef] [PubMed]
- Sanchez-Munoz, F.; Dominguez-Lopez, A.; Yamamoto-Furusho, J.K. Role of cytokines in inflammatory bowel disease. World J. Gastroenterol. 2008, 14, 4280–4288. [Google Scholar] [CrossRef] [PubMed]
- Pence, B.D.; DiPietro, L.A.; Woods, J.A. Exercise speeds cutaneous wound healing in high-fat diet-induced obese mice. Med. Sci. Sports. Exerc. 2012, 44, 1846–1854. [Google Scholar] [CrossRef] [PubMed]
- Kawanishi, N.; Niihara, H.; Mizokami, T.; Yada, K.; Suzuki, K. Exercise training attenuates neutrophil infiltration and elastase expression in adipose tissue of high-fat-diet-induced obese mice. Physiol. Rep. 2015, 3, e12534. [Google Scholar] [CrossRef] [PubMed]
- He, Y.; Lin, L.-J.; Zheng, C.-Q.; Jin, Y.; Lin, Y. Cytokine expression and the role of Th17 cells in a mouse model of colitis. Mol. Med. Rep. 2012, 6, 1438–1442. [Google Scholar] [PubMed]
- Zhang, Z.; Zheng, M.; Bindas, J.; Schwarzenberger, P.; Kolls, J.K. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 2006, 12, 382–388. [Google Scholar] [CrossRef] [PubMed]
- Acedo, S.C.; Gotardo, E.M.; Lacerda, J.M.; de Oliveira, C.C.; de Oliveira Carvalho, P.; Gambero, A. Perinodal adipose tissue and mesenteric lymph node activation during reactivated TNBS-colitis in rats. Dig. Dis. Sci. 2011, 56, 2545–2552. [Google Scholar] [CrossRef] [PubMed]
- Gambero, A.; Marostica, M.; Abdalla Saad, M.J.; Pedrazzoli, J., Jr. Mesenteric adipose tissue alterations resulting from experimental reactivated colitis. Inflamm. Bowel Dis. 2007, 13, 1357–1364. [Google Scholar] [CrossRef] [PubMed]
- Karagiannides, I.; Kokkotou, E.; Tansky, M.; Tchkonia, T.; Giorgadze, N.; O’Brien, M.; Leeman, S.E.; Kirkland, J.L.; Pothoulakis, C. Induction of colitis causes inflammatory responses in fat depots: Evidence for substance P pathways in human mesenteric preadipocytes. Proc. Natl. Acad. Sci. USA 2006, 103, 5207–5212. [Google Scholar] [CrossRef] [PubMed]
- Koon, H.W.; Kim, Y.S.; Xu, H.; Kumar, A.; Zhao, D.; Karagiannides, I.; Dobner, P.R.; Pothoulakis, C. Neurotensin induces IL-6 secretion in mouse preadipocytes and adipose tissues during 2,4,6,-trinitrobenzensulphonic acid-induced colitis. Proc. Natl. Acad. Sci. USA 2009, 106, 8766–8771. [Google Scholar] [CrossRef] [PubMed]
- Barbier, M.; Cherbut, C.; Aube, A.C.; Blottiere, H.M.; Galmiche, J.P. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998, 43, 783–790. [Google Scholar] [CrossRef] [PubMed]
- Olivier, I.; Theodorou, V.; Valet, P.; Castan-Laurell, I.; Ferrier, L.; Eutamene, H. Modifications of mesenteric adipose tissue during moderate experimental colitis in mice. Life Sci. 2014, 94, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Singh, U.P.; Singh, N.P.; Guan, H.; Busbee, B.; Price, R.L.; Taub, D.D.; Mishra, M.K.; Fayad, R.; Nagarkatti, M.; Nagarkatti, P.S. Leptin antagonist ameliorates chronic colitis in IL-10−/− mice. Immunobiology 2013, 218, 1439–1451. [Google Scholar] [CrossRef] [PubMed]
- Kaser, A.; Tilg, H. “Metabolic aspects” in inflammatory bowel diseases. Curr. Drug Deliv. 2012, 9, 326–332. [Google Scholar] [CrossRef] [PubMed]
- Olivier, I.; Theodorou, V.; Valet, P.; Castan-Laurell, I.; Guillou, H.; Bertrand-Michel, J.; Cartier, C.; Bezirard, V.; Ducroc, R.; Segain, J.P.; et al. Is Crohn’s creeping fat an adipose tissue? Inflamm. Bowel Dis. 2011, 17, 747–757. [Google Scholar] [CrossRef] [PubMed]
- McCaskey, S.J.; Rondini, E.A.; Langohr, I.M.; Fenton, J.I. Differential effects of energy balance on experimentally-induced colitis. World J. Gastroenterol. 2012, 18, 627–636. [Google Scholar] [CrossRef] [PubMed]
- Ponemone, V.; Keshavarzian, A.; Brand, M.I.; Saclarides, T.; Abcarian, H.; Cabay, R.J.; Fletcher, E.; Larsen, B.; Durstine, L.J.; Fantuzzi, G.; et al. Apoptosis and inflammation: Role of adipokines in inflammatory bowel disease. Clin. Transl. Gastroenterol. 2010, 1, e1–e12. [Google Scholar] [CrossRef] [PubMed]
- Biesiada, G.; Czepiel, J.; Ptak-Belowska, A.; Targosz, A.; Krzysiek-Maczka, G.; Strzalka, M.; Konturek, S.J.; Brzozowski, T.; Mach, T. Expression and release of leptin and proinflammatory cytokines in patients with ulcerative colitis and infectious diarrhea. J. Physiol. Pharmacol. 2012, 63, 471–481. [Google Scholar] [PubMed]
- Barbier, M.; Vidal, H.; Desreumaux, P.; Dubuquoy, L.; Bourreille, A.; Colombel, J.F.; Cherbut, C.; Galmiche, J.P. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol. Clin. Biol. 2003, 27, 987–991. [Google Scholar] [CrossRef]
- Rodrigues, V.S.; Milanski, M.; Fagundes, J.J.; Torsoni, A.S.; Ayrizono, M.L.; Nunez, C.E.; Dias, C.B.; Meirelles, L.R.; Dalal, S.; Coy, C.S.; et al. Serum levels and mesenteric fat tissue expression of adiponectin and leptin in patients with Crohn’s disease. Clin. Exp. Immunol. 2012, 170, 358–364. [Google Scholar] [CrossRef] [PubMed]
- Yamamoto, K.; Kiyohara, T.; Murayama, Y.; Kihara, S.; Okamoto, Y.; Funahashi, T.; Ito, T.; Nezu, R.; Tsutsui, S.; Miyagawa, J.I.; et al. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn’s disease. Gut 2005, 54, 789–796. [Google Scholar] [CrossRef] [PubMed]
- Chandran, M.; Phillips, S.A.; Ciaraldi, T.; Henry, R.R. Adiponectin: More than just another fat cell hormone? Diabetes Care 2003, 26, 2442–2450. [Google Scholar] [CrossRef] [PubMed]
- Matsuzawa, Y. Adiponectin: A key player in obesity related disorders. Curr. Pharm. Des. 2010, 16, 1896–1901. [Google Scholar] [CrossRef] [PubMed]
- Schaffler, A.; Scholmerich, J.; Buchler, C. Mechanisms of disease: Adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2, 103–111. [Google Scholar] [CrossRef] [PubMed]
- Schaffler, A.; Herfarth, H. Creeping fat in Crohn’s disease: Travelling in a creeper lane of research? Gut 2005, 54, 742–744. [Google Scholar] [CrossRef] [PubMed]
- Weigert, J.; Obermeier, F.; Neumeier, M.; Wanninger, J.; Filarsky, M.; Bauer, S.; Aslanidis, C.; Rogler, G.; Ott, C.; Schaffler, A.; et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn’s disease. Inflamm. Bowel Dis. 2010, 16, 630–637. [Google Scholar] [CrossRef] [PubMed]
- Valentini, L.; Wirth, E.K.; Schweizer, U.; Hengstermann, S.; Schaper, L.; Koernicke, T.; Dietz, E.; Norman, K.; Buning, C.; Winklhofer-Roob, B.M.; et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009, 25, 172–181. [Google Scholar] [CrossRef] [PubMed]
- Karmiris, K.; Koutroubakis, I.E.; Kouroumalis, E.A. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease. Mol. Nutr. Food Res. 2008, 52, 855–866. [Google Scholar] [CrossRef] [PubMed]
- Mathur, N.; Pedersen, B.K. Exercise as a mean to control low-grade systemic inflammation. Mediat. Inflamm. 2008, 2008, 109502. [Google Scholar] [CrossRef] [PubMed]
- Bruunsgaard, H. Physical activity and modulation of systemic low-level inflammation. J. Leukoc. Biol. 2005, 78, 819–835. [Google Scholar] [CrossRef] [PubMed]
- Bilski, J.; Jaworek, J.; Pokorski, J.; Nitecki, J.; Nitecka, E.; Pokorska, J.; Mazur-Bialy, A.; Szklarczyk, J. Effects of time of day and the Wingate test on appetite perceptions, food intake and plasma levels of adipokines. J. Physiol. Pharmacol. 2016, 67, 667–676. [Google Scholar] [PubMed]
- Liu, W.X.; Zhou, F.; Wang, Y.; Wang, T.; Xing, J.W.; Zhang, S.; Sang, L.X.; Gu, S.Z.; Wang, H.L. Voluntary exercise protects against ulcerative colitis by up-regulating glucocorticoid-mediated PPAR-gamma activity in the colon in mice. Acta Physiol. (Oxf.) 2015, 215, 24–36. [Google Scholar] [CrossRef] [PubMed]
- Pedersen, B.K. Muscles and their myokines. J. Exp. Biol. 2011, 214, 337–346. [Google Scholar] [CrossRef] [PubMed]
- Tsuchida, K. Myokines and Signal Crosstalk between Skeletal Muscle and Adipose Tissue. Austin J. Endocrinol. Diabetes 2014, 3, 1–2. [Google Scholar]
- Bostrom, P.; Wu, J.; Jedrychowski, M.P.; Korde, A.; Ye, L.; Lo, J.C.; Rasbach, K.A.; Bostrom, E.A.; Choi, J.H.; Long, J.Z.; et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481, 463–468. [Google Scholar] [CrossRef] [PubMed]
- Lee, P.; Linderman, J.D.; Smith, S.; Brychta, R.J.; Wang, J.; Idelson, C.; Perron, R.M.; Werner, C.D.; Phan, G.Q.; Kammula, U.S.; et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014, 19, 302–309. [Google Scholar] [CrossRef] [PubMed]
- Cereijo, R.; Giralt, M.; Villarroya, F. Thermogenic brown and beige/brite adipogenesis in humans. Ann. Med. 2015, 47, 169–177. [Google Scholar] [CrossRef] [PubMed]
- Chen, J.Q.; Huang, Y.Y.; Gusdon, A.M.; Qu, S. Irisin: A new molecular marker and target in metabolic disorder. Lipids Health Dis. 2015, 14, 2. [Google Scholar] [CrossRef] [PubMed]
- Rocha-Rodrigues, S.; Rodriguez, A.; Gouveia, A.M.; Goncalves, I.O.; Becerril, S.; Ramirez, B.; Beleza, J.; Fruhbeck, G.; Ascensao, A.; Magalhaes, J. Effects of physical exercise on myokines expression and brown adipose-like phenotype modulation in rats fed a high-fat diet. Life Sci. 2016, 165, 100–108. [Google Scholar] [CrossRef] [PubMed]
- Wu, M.V.; Bikopoulos, G.; Hung, S.; Ceddia, R.B. Thermogenic capacity is antagonistically regulated in classical brown and white subcutaneous fat depots by high fat diet and endurance training in rats: Impact on whole-body energy expenditure. J. Biol. Chem. 2014, 289, 34129–34140. [Google Scholar] [CrossRef] [PubMed]
- Moreno-Navarrete, J.M.; Ortega, F.; Serrano, M.; Guerra, E.; Pardo, G.; Tinahones, F.; Ricart, W.; Fernandez-Real, J.M. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 2013, 98, E769–E778. [Google Scholar] [CrossRef] [PubMed]
- Roca-Rivada, A.; Castelao, C.; Senin, L.L.; Landrove, M.O.; Baltar, J.; Belen Crujeiras, A.; Seoane, L.M.; Casanueva, F.F.; Pardo, M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS ONE 2013, 8, e60563. [Google Scholar] [CrossRef] [PubMed]
- Sideri, A.; Bakirtzi, K.; Shih, D.Q.; Koon, H.W.; Fleshner, P.; Arsenescu, R.; Arsenescu, V.; Turner, J.R.; Karagiannides, I.; Pothoulakis, C. Substance P Mediates Proinflammatory Cytokine Release From Mesenteric Adipocytes in Inflammatory Bowel Disease Patients. CMGH Cell. Mol. Gastroenterol. Hepatol. 2015, 1, 420–432. [Google Scholar] [CrossRef] [PubMed]
- Hagel, A.; De Rossi, T.; Konturek, P.; Albrecht, H.; Walker, S.; Hahn, E.; Raithel, M. Plasma histamine and tumor necrosis factor-alpha levels in Crohn’s disease and ulcerative colitis at various stages of disease. J. Physiol. Pharmacol. 2015, 66, 549–556. [Google Scholar] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mazur-Bialy, A.I.; Bilski, J.; Wojcik, D.; Brzozowski, B.; Surmiak, M.; Hubalewska-Mazgaj, M.; Chmura, A.; Magierowski, M.; Magierowska, K.; Mach, T.; et al. Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers. Nutrients 2017, 9, 410. https://doi.org/10.3390/nu9040410
Mazur-Bialy AI, Bilski J, Wojcik D, Brzozowski B, Surmiak M, Hubalewska-Mazgaj M, Chmura A, Magierowski M, Magierowska K, Mach T, et al. Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers. Nutrients. 2017; 9(4):410. https://doi.org/10.3390/nu9040410
Chicago/Turabian StyleMazur-Bialy, Agnieszka Irena, Jan Bilski, Dagmara Wojcik, Bartosz Brzozowski, Marcin Surmiak, Magdalena Hubalewska-Mazgaj, Anna Chmura, Marcin Magierowski, Katarzyna Magierowska, Tomasz Mach, and et al. 2017. "Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers" Nutrients 9, no. 4: 410. https://doi.org/10.3390/nu9040410
APA StyleMazur-Bialy, A. I., Bilski, J., Wojcik, D., Brzozowski, B., Surmiak, M., Hubalewska-Mazgaj, M., Chmura, A., Magierowski, M., Magierowska, K., Mach, T., & Brzozowski, T. (2017). Beneficial Effect of Voluntary Exercise on Experimental Colitis in Mice Fed a High-Fat Diet: The Role of Irisin, Adiponectin and Proinflammatory Biomarkers. Nutrients, 9(4), 410. https://doi.org/10.3390/nu9040410